Monday 16 November 2026
Export DYAI’s income statement to Excel — free account
Dyadic International Inc.
DYAIDyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.
- Revenue
- −61.4%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +0.80%
Quarter to September 2026, against a year earlier
0.33
0.02
−5.71%
Follow DYAI
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 0.0% in Q3 FY26, the highest of these four quarters.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | −397.8% | −2826.8% | 522.6% | −47310.8% |
| ROIC | 0.0% | 0.0% | 0.0% | 0.0% |
Debt
It holds more cash than debt: net debt is −0.18× a year’s EBITDA.
| Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|
| Net debt / EBITDA | 2.7× | 2.3× | 0.8× | −0.2× |
Cash cycle, in days
Customers pay in 0 days and suppliers are paid in 219. Suppliers fund 219 days of working capital.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Cash cycle | −1 | −41 | 33 | −219 |
| Days to pay suppliers | 134 | 138 | 94 | 219 |
| Days to be paid | 133 | 97 | 127 | 0 |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has fallen 14.9%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Revenue | 1.0× | 1.1× | 1.1× | 0.9× |
| Book value | 1.0× | −0.3× | −1.7× | −1.8× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 13 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 2 | 2 | 2 |
| (397.80%) | (2,826.83%) | 522.58% | (47,310.78%) | ||
| (74.11%) | (92.86%) | (103.88%) | (71.43%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(118.61%) | (161.47%) | (301.98%) | (217.54%) | |
Average Days of Receivables |
132.92 | 96.71 | 126.57 | 0.00 | |
Free Cash Flow per Share |
(0.17) | (0.16) | (0.20) | (0.18) | |
Free Cash Flow |
(5.70) | (5.72) | (7.40) | (7.04) | |
| Other line items | |||||
Cash ROIC |
(38.50%) | (51.30%) | (101.10%) | 272.94% | |
Accounts Receivable Turnover |
4.46 | 6.07 | 3.68 | 0.00 | |
Accounts Payable Turnover |
3.48 | 3.73 | 4.10 | 1.86 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
134.05 | 137.50 | 93.54 | 219.11 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
69.72% | 56.09% | 48.37% | 54.98% | |
Selling, General and Administrative Expense of Revenue |
186.44% | 155.49% | 162.38% | 199.03% | |
Share Based Compensation of Revenue |
30.10% | 22.18% | 17.05% | 20.02% | |
Interest Coverage |
(15.78) | (15.74) | (16.62) | — | |
Operating CF/Net income |
0.77 | 0.78 | 0.97 | 1.00 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.09 | 0.10 | 0.10 | 0.08 | |
Operating CF per Share |
(0.17) | (0.16) | (0.20) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 13 Nov 2026